GCNC World View: The Global Cannabis Business Podcast · GCNC

GCNC World View: France & Cannabis: What’s The Score?

·37 min

Augur Associates co-founders Benjamin and Aurélien discuss France's evolving medical cannabis regulatory landscape and European market opportunities. From UN drug policy reform background to building hemp unions, they detail the 3000-patient trial results, anticipated decree signing, and France's positioning as a top European market. Discussion contrasts with Germany-focused narrative, emphasizing regulatory framework design and 2000-3000 trained medical professionals.

As heard by us

A clear look at France's cannabis rollout, with policy detail that sharpens the business picture.

France's medical cannabis market is the subject here, with the discussion tracking where the regulatory process stands, what has already been tested, and why the next step matters for the people involved.

Read the full review in PlayNext →

Why you'd press play

Want the clearest current read on where France's medical cannabis rollout stands?

Read the full recommendation in PlayNext →

Listen to the show on

Apple Podcasts Spotify